PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 12, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of approximately 35% and 33%, respectively, for the third quarter ended October 4, 2020. The strong revenue growth performance was driven by continued better-than-expected demand for PerkinElmer’s... Read more

CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 12, 2020– The table in the release was incorrect. The corrected table should read: PerkinElmer, Inc: PerkinElmer, Inc. and SubsidiariesRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)     PKI Three Months Ended October 4, 2020 Organic revenue growth: Reported revenue growth 35% Less: effect of foreign exchange rates 1% Less: effect... Read more

Newport, Wales Laboratory Goes Live as First Lighthouse Lab featuring PerkinElmer’s COVID-19 Solutions

Company’s RT-PCR kits and workflow solutions will help to significantly increase capacity of the UK’s testing program WALTHAM, Mass. – October 8, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the first Turnkey Lighthouse lab in Newport, South Wales, is now processing COVID-19 testing samples as... Read more

Danaher Schedules Third Quarter 2020 Earnings Conference Call

WASHINGTON, Oct. 7, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2020 on Thursday, October 22, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

PerkinElmer Launches Industry First, Fully Automated Workflow for Cannabis & Hemp Pesticide Residue Testing

Streamlined solution features quality control reagent kits, robotic sample preparation, mass spectrometry analysis and data reporting software to transform analysis efficiency WALTHAM, Mass. – October 7, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the cannabis industry’s first fully-automated liquid handling sample preparation and LC/MS/MS analysis workflow... Read more

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2020

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2020 WALTHAM, Mass., Oct. 5, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter of 2020 before the market opens on Wednesday, October 21, 2020, and... Read more

PerkinElmer Signals Notebook and PerkinElmer Signals Medical Review Cloud-Based Software Gain SOC 2 Attestation for Biopharmaceutical Research and Clinical Trial Data

Company’s Informatics Solutions Meet AICPA’s Trust Service Principles for Security, Confidentiality & Availability WALTHAM, Mass. –  September 30, 2020  –  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the PerkinElmer Signals™ Notebook and PerkinElmer Signals™ Medical Review SaaS solutions have been granted SOC 2 Level 1 Attestation for... Read more

PerkinElmer EONIS Screening Test Receives CE-IVD Clearance

RT-PCR Newborn Screening Assay for SMA, SCID and XLA to be Integrated into Company’s Sample-to-Result Workflow WALTHAM, Mass. – September 30, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the Company’s EONIS™ screening assay for newborns that simultaneously tests for SMA (spinal muscular atrophy), SCID (severe... Read more

Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies

IP2 Accelerates CCS-enabled 4D-Proteomics™ with GPU-based Scalable Search Engine IP2 Adds ‘Run & Done’ Real-Time Capabilities to timsTOF® Proteomics Systems BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announces the recent acquisition of the Integrated Proteomics Pipeline (IP2) search engine and proteomics workflow software platform. IP2 was developed by Integrated Proteomics Applications Inc, a company founded... Read more

Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions

Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions Program will leverage Ion Torrent Genexus System* and Oncomine Precision Assay* to advance precision medicine for lung cancer in Asia CARLSBAD, Calif., Sept. 29, 2020 /PRNewswire/ — LC-SCRUM-Asia, a leading cancer genomic screening program, has selected Thermo Fisher Scientific’s Ion Torrent Genexus System* and Oncomine Precision... Read more